JOINSTAR BIOMEDICAL TECHNOLOGY E-AACC CHICAGO 2022

I-AACC2022

Indawo ye-Booth763 

Chicago26-28Julayi 2022

JI-OINSTAR BIOMEDICAL TECHNOLOGYCO.LTD., bayakujabulela ukumemezela ukuhlanganyela kwethu eI-AACCUmbukiso e-Chicago kulo nyaka.

Singajabula ukuhlangana nawe endaweni yethu Uma uhlela ukuya embukisweni walo nyaka.

JOINSTARisomunye wabakhiqizi abahamba phambili be-Point-of-Care e-China abanezilinganiso ezingaphezu kuka-25 ezisekelwe kubuchwepheshe bokuhlola i-Dry Immunofluorescence.Iphothifoliyo yethu yomkhiqizo ebanzi ihlanganisa izindawo zezifo ezifana Iisifo sokuthelelekas, Inhliziyo, Isifo sezinso, impilo yokuzala njll. I-Joinstar ingumgijimi ophambili ekuphathweni kwe-Sepsis ngokutholakala kokuhlolwa kwe-POCT yenoveli ye-biomarker enelungelo lobunikazi, i-Heparin Binding Protein (HBP).Le noveli biomarker ikhonjiswe ukuthi iyinkomba engcono yokubikezela ku-sepsis uma iqhathaniswa nezivivinyo zamanje ezaziwayo.Ngaphezu kwe-HBP, i-Joinstar iyona kuphela inkampani ehlanganisa iphaneli ye-Sepsis ephelele ku-repertoire yayo, okuhlanganisa ukuhlolwa kwe-PCT ne-IL-6.Phakathi nobhubhane lwakamuva lwe-Covid 19 lezi zivivinyo, ikakhulukazi i-HBP, kukhonjiswe ukuthi zibalulekile ekulawuleni izifo kanye nemininingwane yakamuva evela ezincwadini ezimbalwa zibonisa ukuthiI-HBP ingabikezela ukwehluleka kokuphefumula kanye nokufa kwezinsuku ezingama-28 ezigulini ze-COVID-19futhi futhianIsici esizimele sengozi yokufa)   

Ukuze uthole ulwazi olwengeziwe, sicela uxhumaneusngokuqondile noma vakashela iwebhusayithi yethu: https://www.joinstar.com/jet-istar-platform/

ukuze uthole imininingwane yokuxhumana, sicelai-imeyili ku:info@joinstar.cn- wngibheke ngabomvu ukuzwa okuvela kuwe, futhi ngethemba ukukubona e-Chicago!Woza uzosibona, e-Joinstar booth#763futhi ufunde konke mayelana nohlu lwethu olujabulisayo lwemikhiqizo namathuluzi.


Isikhathi sokuthumela: Jun-20-2022